127 related articles for article (PubMed ID: 12013148)
1. Effect of an Na+/H+ exchange inhibitor, SM-20550, on ischemic preconditioning in rabbits.
Yamada K; Matsui K; Yamamoto S; Kitano M; Ohashi N
Int J Tissue React; 2002; 24(1):1-10. PubMed ID: 12013148
[TBL] [Abstract][Full Text] [Related]
2. Reduction of myocardial infarct size by SM-197378, a novel Na+/H+ exchange inhibitor, in rabbits.
Yamada K; Matsui K; Ogawa S; Yamamoto S; Mori M; Kitano M; Ohashi N
Eur J Pharmacol; 2005 Oct; 521(1-3):115-23. PubMed ID: 16183058
[TBL] [Abstract][Full Text] [Related]
3. The effect of an Na+/H+ exchange inhibitor, SM-20550, on ischemia/reperfusion-induced endothelial dysfunction in isolated perfused rat hearts.
Yamamoto S; Matsui K; Itoh N; Ohashi N
Int J Tissue React; 2001; 23(1):1-7. PubMed ID: 11392059
[TBL] [Abstract][Full Text] [Related]
4. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
Das B; Sarkar C
J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
[TBL] [Abstract][Full Text] [Related]
5. Differential role of Pim-1 kinase in anesthetic-induced and ischemic preconditioning against myocardial infarction.
Stumpner J; Redel A; Kellermann A; Lotz CA; Blomeyer CA; Smul TM; Kehl F; Roewer N; Lange M
Anesthesiology; 2009 Dec; 111(6):1257-64. PubMed ID: 19934869
[TBL] [Abstract][Full Text] [Related]
6. Effects of SM-20550, a new Na(+)/H(+) exchange inhibitor, on survival and infarct size in rat myocardial infarction.
Yamada K; Sasabe M; Matsui K; Yamamoto S; Ohashi N
Pharmacology; 2002 Apr; 64(4):176-81. PubMed ID: 11893897
[TBL] [Abstract][Full Text] [Related]
7. Preischaemic as well as postischaemic application of a Na+/H+ exchange inhibitor reduces infarct size in pigs.
Rohmann S; Weygandt H; Minck KO
Cardiovasc Res; 1995 Dec; 30(6):945-51. PubMed ID: 8746210
[TBL] [Abstract][Full Text] [Related]
8. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
[TBL] [Abstract][Full Text] [Related]
9. Duration of ischaemic preconditioning and importance of size of area at risk in pigs.
Grund F; Gjesdal K; Kirkeboen KA; Ilebekk A
J Mol Cell Cardiol; 1999 Jul; 31(7):1369-80. PubMed ID: 10403754
[TBL] [Abstract][Full Text] [Related]
10. Delayed treatment of Na+/H+ exchange inhibitor SM-20220 reduces infarct size in both transient and permanent middle cerebral artery occlusion in rats.
Kuribayashi Y; Horikawa N; Itoh N; Kitano M; Ohashi N
Int J Tissue React; 1999; 21(2):29-33. PubMed ID: 10568221
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological preconditioning by levosimendan is mediated by inducible nitric oxide synthase and mitochondrial KATP channel activation in the in vivo anesthetized rabbit heart model.
Das B; Sarkar C
Vascul Pharmacol; 2007 Oct; 47(4):248-56. PubMed ID: 17728191
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent protection by Na+/H+ exchange inhibition in a regionally ischemic, reperfused porcine heart preparation with low residual blood flow.
Klein HH; Bohle RM; Pich S; Lindert-Heimberg S; Wollenweber J; Schade-Brittinger C; Nebendahl K
J Mol Cell Cardiol; 1998 Apr; 30(4):795-801. PubMed ID: 9602428
[TBL] [Abstract][Full Text] [Related]
13. Reduction of myocardial infarct size by SM-20550, a novel Na(+)/H(+) exchange inhibitor, in rabbits.
Yamada K; Matsui K; Satoh K; Kitano M; Yamamoto S; Ohashi N
Eur J Pharmacol; 2000 Sep; 404(1-2):201-12. PubMed ID: 10980280
[TBL] [Abstract][Full Text] [Related]
14. Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo.
Iliodromitis EK; Tasouli A; Andreadou I; Bofilis E; Zoga A; Cokkinos P; Kremastinos DT
Eur J Pharmacol; 2004 Sep; 499(1-2):163-9. PubMed ID: 15363963
[TBL] [Abstract][Full Text] [Related]
15. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
[TBL] [Abstract][Full Text] [Related]
16. Ischemic preconditioning in immature hearts: mechanism and compatibility with cardioplegia.
Zhu B; Min S; Long C; Ye T
Chin Med J (Engl); 2003 Feb; 116(2):253-7. PubMed ID: 12775242
[TBL] [Abstract][Full Text] [Related]
17. Reduction of myocardial infarct size by SM-198110, a novel Na+/H+ exchange inhibitor, in rabbits.
Yamada K; Matsui K; Ogawa S; Yamamoto S; Mori M; Kitano M; Ohashi N
Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):408-19. PubMed ID: 15902428
[TBL] [Abstract][Full Text] [Related]
18. A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary artery occlusion.
Gumina RJ; Mizumura T; Beier N; Schelling P; Schultz JJ; Gross GJ
J Pharmacol Exp Ther; 1998 Jul; 286(1):175-83. PubMed ID: 9655858
[TBL] [Abstract][Full Text] [Related]
19. Differences in the effects of Na+-H+ exchange inhibitors on cardiac function and apoptosis in guinea-pig ischemia-reperfused hearts.
Hotta Y; Nishimaki H; Takeo T; Itoh G; Yajima M; Otsuka-Murakami H; Ishikawa N; Kawai N; Huang L; Yamada K; Yamamoto S; Matsui K; Ohashi N
Eur J Pharmacol; 2004 Oct; 503(1-3):109-22. PubMed ID: 15496305
[TBL] [Abstract][Full Text] [Related]
20. Effect of sodium/hydrogen exchange inhibition on myocardial infarct size after coronary artery thrombosis and thrombolysis.
Hennan JK; Driscoll EM; Barrett TD; Fischbach PS; Lucchesi BR
Pharmacology; 2006; 78(1):27-37. PubMed ID: 16899991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
